newsfilter
← Latest News
PR Newswire·

Mallinckrodt Provides a Regulatory Update on Terlipressin

DUBLIN, Feb. 22, 2022 /PRNewswire/ -- Mallinckrodt plc (OTC:MNKKQ), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the Company's New Drug Applica